Sorrento Therapeutics, Inc. (SRNE)

USD 0.0

(0.0%)

Total Liabilities Summary of Sorrento Therapeutics, Inc.

  • Sorrento Therapeutics, Inc.'s latest annual total liabilities in 2022 was 494.5 Million USD , down -19.81% from previous year.
  • Sorrento Therapeutics, Inc.'s latest quarterly total liabilities in 2023 Q2 was 654.64 Million USD , up 11.43% from previous quarter.
  • Sorrento Therapeutics, Inc. reported annual total liabilities of 616.68 Million USD in 2021, up 56.09% from previous year.
  • Sorrento Therapeutics, Inc. reported annual total liabilities of 395.09 Million USD in 2020, down -24.73% from previous year.
  • Sorrento Therapeutics, Inc. reported quarterly total liabilities of 654.64 Million USD for 2023 Q2, up 11.43% from previous quarter.
  • Sorrento Therapeutics, Inc. reported quarterly total liabilities of 494.5 Million USD for 2022 Q4, up 1.87% from previous quarter.

Annual Total Liabilities Chart of Sorrento Therapeutics, Inc. (2022 - 2003)

Historical Annual Total Liabilities of Sorrento Therapeutics, Inc. (2022 - 2003)

Year Total Liabilities Total Liabilities Growth
2022 494.5 Million USD -19.81%
2021 616.68 Million USD 56.09%
2020 395.09 Million USD -24.73%
2019 524.87 Million USD 12.34%
2018 467.22 Million USD 71.04%
2017 273.16 Million USD -13.3%
2016 315.08 Million USD 55.53%
2015 202.58 Million USD 517.1%
2014 32.82 Million USD 27.37%
2013 25.77 Million USD 4311.86%
2012 584.17 Thousand USD 62.57%
2011 359.33 Thousand USD -40.5%
2010 603.95 Thousand USD 71.06%
2009 353.07 Thousand USD 15040.22%
2008 2332.00 USD -29.01%
2007 3285.00 USD -99.3%
2006 471.78 Thousand USD 1351.65%
2005 32.5 Thousand USD -90.46%
2004 340.53 Thousand USD 0.22%
2003 339.76 Thousand USD 0.0%

Peer Total Liabilities Comparison of Sorrento Therapeutics, Inc.

Name Total Liabilities Total Liabilities Difference
America Great Health 4.82 Million USD -10148.966%
Ampio Pharmaceuticals, Inc. 2.37 Million USD -20712.668%
Aridis Pharmaceuticals, Inc. 38.92 Million USD -1170.35%
Biora Therapeutics, Inc. 132.63 Million USD -272.832%
Bio-Path Holdings, Inc. 2.77 Million USD -17694.494%
Better Therapeutics, Inc. 23.84 Million USD -1974.109%
Calithera Biosciences, Inc. 8.28 Million USD -5869.447%
Comera Life Sciences Holdings, Inc. 9.97 Million USD -4857.881%
Gene Biotherapeutics, Inc. - USD -Infinity%
eFFECTOR Therapeutics, Inc. 26.33 Million USD -1777.478%
Eloxx Pharmaceuticals, Inc. 31.78 Million USD -1455.892%
Evelo Biosciences, Inc. 69.43 Million USD -612.21%
Evolutionary Genomics, Inc. 7.94 Million USD -6123.695%
Finch Therapeutics Group, Inc. 48.11 Million USD -927.85%
Galera Therapeutics, Inc. 157.32 Million USD -214.321%
Innovation1 Biotech Inc. 3.5 Million USD -14004.826%
Kiromic BioPharma, Inc. 21.28 Million USD -2222.751%
Molecular Templates, Inc. 31.17 Million USD -1486.439%
Navidea Biopharmaceuticals, Inc. 12.51 Million USD -3851.357%
NexImmune, Inc. 5.08 Million USD -9626.326%
Orgenesis Inc. 35.53 Million USD -1291.611%
Panbela Therapeutics, Inc. 16.51 Million USD -2894.846%
Point of Care Nano-Technology, Inc. 266.41 Thousand USD -185516.747%
PaxMedica, Inc. Common Stock 2.29 Million USD -21444.116%
Scopus BioPharma Inc. 7.45 Million USD -6533.756%
Statera Biopharma, Inc. 22.67 Million USD -2080.716%
TRACON Pharmaceuticals, Inc. 10.91 Million USD -4430.96%
Trevena, Inc. 48.26 Million USD -924.634%
Vaxxinity, Inc. 30.94 Million USD -1498.077%
Vaccinex, Inc. 5.94 Million USD -8222.265%
Vicapsys Life Sciences, Inc. 1.96 Million USD -25023.188%
Viracta Therapeutics, Inc. 38.37 Million USD -1188.69%
ZIVO Bioscience, Inc. 2.76 Million USD -17806.884%